Abstract
The number of 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) and PET/computed tomography (CT) examinations that are performed is rapidly increasing. A total of 308,663 FDG PET and PET/CT examinations were performed in Korea in 2009 compared with 66 examinations conducted in 1994, when the first PET was installed (The Korean Society of Nuclear Medicine, Nuclear medicine procedures statistics over 48 years: year 2009, 2009). In the US, probably more than 1.5 million PET and PET/CT patient studies were performed per year in recent years.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
The Korean Society of Nuclear Medicine. Nuclear medicine procedures statistics over 48 years: year 2009; 2009.
Choi J, Kim B. Whole body positron emission tomography/computed tomography. J Korean Med Assoc. 2006;49:1027–34.
Czernin J, Phelps ME. Positron emission tomography scanning: current and future applications. Annu Rev Med. 2002;53:89–112.
Cameron J. Radiation dosimetry. Environ Health Perspect. 1991;91:45–8.
ICRP. Recommendations of the international commission on radiological protection. ICRP Publication 60. Ann ICRP. 1991;21(1–3).
Mejia AA, Nakamura T, Itoh M, et al. Absorbed dose estimates in positron emission tomography Âstudies based on the administration of 18F-labeled radioÂpharmaceuticals. J Radiat Res (Tokyo). 1991; 32(3):243–61.
Deloar HM, Fujiwara T, Shidahara M, et al. Estimation of absorbed dose for 2-[F-18]fluoro-2-deoxy-d-glucose using whole-body positron emission tomography and magnetic resonance imaging. Eur J Nucl Med. 1998;25(6):565–74.
Gelfand MJ. Dosimetry of FDG PET/CT and other molecular imaging applications in pediatric patients. Pediatr Radiol. 2009;39(Suppl 1):S46–56.
Brix G, Lechel U, Glatting G, et al. Radiation exposure of patients undergoing whole-body dual-modality 18F-FDG PET/CT examinations. J Nucl Med. 2005;46(4):608–13.
Brix G, Nekolla EA, Nosske D, Griebel J. Risks and safety aspects related to PET/MR examinations. Eur J Nucl Med Mol Imaging. 2009;36(Suppl 1):S131–8.
Committee to assess health risks from exposure to low levels of ionizing radiation, National Research Council. Health risks from exposure to low levels of ionizing radiation: BEIR VII phase 2. Washington, DC: The National Academy Press; 2006.
Huang B, Law MW, Khong PL. Whole-body PET/CT scanning: estimation of radiation dose and cancer risk. Radiology. 2009;251(1):166–74.
Mossman KL. The linear no-threshold debate: where do we go from here? Med Phys. 1998;25(3):279–84. discussion 300.
Fahey FH. Dosimetry of pediatric PET/CT. J Nucl Med. 2009;50(9):1483–91.
Wu TH, Chu TC, Huang YH, et al. A positron emission tomography/computed tomography (PET/CT) acquisition protocol for CT radiation dose optimization. Nucl Med Commun. 2005;26(4):323–30.
Beyer T, Townsend DW, Brun T, et al. A combined PET/CT scanner for clinical oncology. J Nucl Med. 2000;41(8):1369–79.
Brix G, Beyer T. PET/CT: dose-escalated image fusion? Nuklearmedizin. 2005;44(Suppl 1):S51–7.
Fahey FH, Palmer MR, Strauss KJ, Zimmerman RE, Badawi RD, Treves ST. Dosimetry and adequacy of CT-based attenuation correction for pediatric PET: phantom study. Radiology. 2007;243(1):96–104.
Groves AM, Owen KE, Courtney HM, et al. 16-detector multislice CT: dosimetry estimation by TLD measurement compared with Monte Carlo simulation. Br J Radiol. 2004;77(920):662–5.
Huda W, Vance A. Patient radiation doses from adult and pediatric CT. AJR Am J Roentgenol. 2007; 188(2):540–6.
Zanzonico P, Dauer L, St Germain J. Operational radiation safety for PET-CT, SPECT-CT, and cyclotron facilities. Health Phys. 2008;95(5):554–70.
Hany TF, Steinert HC, Goerres GW, Buck A, von Schulthess GK. PET diagnostic accuracy: improvement with in-line PET-CT system: initial results. Radiology. 2002;225(2):575–81.
Kamel E, Hany TF, Burger C, et al. CT vs 68Ge attenuation correction in a combined PET/CT system: evaluation of the effect of lowering the CT tube current. Eur J Nucl Med Mol Imaging. 2002;29(3):346–50.
Gelfand MJ, Lemen LC. PET/CT and SPECT/CT dosimetry in children: the challenge to the pediatric imager. Semin Nucl Med. 2007;37(5):391–8.
Rohren EM, Turkington TG, Coleman RE. Clinical applications of PET in oncology. Radiology. 2004;231(2):305–32.
Wechalekar K, Sharma B, Cook G. PET/CT in Âoncology–a major advance. Clin Radiol. 2005;60(11):1143–55.
Lee JW, Kang KW, Paeng JC, et al. Cancer screening using 18F-FDG PET/CT in Korean asymptomatic volunteers: a preliminary report. Ann Nucl Med. 2009;23(7):685–91.
American Cancer Society. Cancer facts and figures 2009. Atlanta: American Cancer Society; 2009.
Korea National Statistical Office. Causes of death statistics in 2008. In: Statistics Korea, editor. Annual report on the cause of death statistics, 14 Sept 2009.
Yasunaga H. Who wants cancer screening with PET? A contingent valuation surgery in Japan. Eur J Radiol. 2007;70:190–4.
Kojima S, Zhou B, Teramukai S, et al. Cancer screening of healthy volunteers using whole-body 18F-FDG-PET scans: the Nishidai clinic study. Eur J Cancer. 2007;43(12):1842–8.
Chen YK, Ding HJ, Su CT, et al. Application of PET and PET/CT imaging for cancer screening. Anticancer Res. 2004;24(6):4103–8.
Chung J, Cho H, Shim J, et al. Detection of cancer with PET and PET/CT in asymptomatic volunteers. Nucl Med Mol Imaging. 2009;43(6):526–34.
Weckesser M, Schober O. Is whole-body FDG-PET valuable for health screening? Against. Eur J Nucl Med Mol Imaging. 2005;32(3):342–3.
Yasuda S, Ide M, Fujii H, et al. Application of positron emission tomography imaging to cancer screening. Br J Cancer. 2000;83(12):1607–11.
Minamimoto R, Senda M, Terauchi T, et al. Analysis of various malignant neoplasms detected by FDG-PET cancer screening program: based on a Japanese nationwide survey. Ann Nucl Med. 2011;25(1):45–54.
Yasuda S, Shohtsu A. Cancer screening with whole-body 18F-fluorodeoxyglucose positron-emission tomography. Lancet. 1997;350(9094):1819.
Robbins E. Radiation risks from imaging studies in children with cancer. Pediatr Blood Cancer. 2008;51(4):453–7.
Ide M, Suzuki Y. Is whole-body FDG-PET valuable for health screening? For. Eur J Nucl Med Mol Imaging. 2005;32(3):339–41.
Schoder H, Gonen M. Screening for cancer with PET and PET/CT: potential and limitations. J Nucl Med. 2007;48(Suppl 1):4S–18.
Nishizawa S, Kojima S, Teramukai S, et al. Prospective evaluation of whole-body cancer screening with multiple modalities including [18F]fluorodeoxyglucose positron emission tomography in a healthy population: a preliminary report. J Clin Oncol. 2009;27(11):1767–73.
Zhu X. Dosage of radiopharmaceuticals and internal dosimetry. In: Charron M, editor. Practical pediatric PET imaging. New York: Springer; 2006. p. 37–46.
Cristy M, Eckerman KF. Specific absorbed fractions of energy at various ages from internal photon sources. I. Methods. Oak Ridge National Laboratory Rep. ORNL/TM-8381/V1; 1987.
ICRP. Radiation dose to patients from radiopharmaceuticals (Addendum to ICRP Publication 53). ICRP Publication 80. Ann ICRP. 1998;28(3).
Treves ST, Davis RT, Fahey FH. Administered radiopharmaceutical doses in children: a survey of 13 pediatric hospitals in North America. J Nucl Med. 2008;49(6):1024–7.
Lassmann M, Biassoni L, Monsieurs M, Franzius C. The new EANM paediatric dosage card: additional notes with respect to F-18. Eur J Nucl Med Mol Imaging. 2008;35(9):1666–8.
Pediatric Nuclear Medicine Workgroup. North American consensus guidelines for administered radiopharmaceutical activities in children and adolescents 2010.
Ernst M, Freed ME, Zametkin AJ. Health hazards of radiation exposure in the context of brain imaging research: special consideration for children. J Nucl Med. 1998;39(4):689–98.
Charron M. The biologic effects of low-level radiation. In: Charron M, editor. Practical pediatric PET imaging. New York: Springer; 2006. p. 30–6.
Zanotti-Fregonara P, Champion C, Trebossen R, Maroy R, Devaux JY, Hindie E. Estimation of the beta  +  dose to the embryo resulting from 18F-FDG administration during early pregnancy. J Nucl Med. 2008;49(4):679–82.
ICRP. Pregnancy and medical radiation. ICRP Publication 84. Ann ICRP. 2000;30(1).
Leide-Svegborn S. Radiation exposure of patients and personnel from a PET/CT procedure with 18F-FDG. Radiat Prot Dosimetry. 2010;139(1–3):208–13.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media New York
About this chapter
Cite this chapter
Park, E.A. (2013). Radiation Dosimetry in 18F-FDG PET/CT. In: Kim, E., Lee, MC., Inoue, T., Wong, WH. (eds) Clinical PET and PET/CT. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-0802-5_10
Download citation
DOI: https://doi.org/10.1007/978-1-4419-0802-5_10
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4419-0801-8
Online ISBN: 978-1-4419-0802-5
eBook Packages: MedicineMedicine (R0)